NF-κB-Signaling-Targeted Immunomodulatory Nanoparticle with Photothermal and Quorum-Sensing Inhibition Effects for Efficient Healing of Biofilm-Infected Wounds
Source abstract
Abstract
The development of therapeutics with high antimicrobial activity and immunomodulatory effects is urgently needed for the treatment of infected wounds due to the increasing danger posed by recalcitrant-infected wounds. In this study, we developed light-controlled antibacterial, photothermal, and immunomodulatory biomimetic N/hPDA@M nanoparticles (NPs). This nanoplatform was developed by loading flavonoid naringenin onto hollow mesoporous polydopamine NPs in a π-π-stacked configuration and encasing them with macrophage membranes. First, our N/hPDA@M NPs efficiently neutralized inflammatory factors present within the wound microenvironment by the integration of macrophage membranes. Afterward, the N/hPDA@M NPs effectively dismantled bacterial biofilms through a combination of the photothermal properties of PDA and the quorum sensing inhibitory effects of naringenin. It is worth noting that N/hPDA@M NPs near-infrared-enhanced release of naringenin exhibited specificity toward the NF-κB-signaling pathway, effectively mitigating the inflammatory response. This innovative design not only conferred remarkable antibacterial properties upon the N/hPDA@M NPs but also endowed them with the capacity to modulate inflammatory responses, curbing excessive inflammation and steering macrophage polarization toward the M2 phenotype. As a result, this multifaceted approach significantly contributes to expediting the healing process of infected skin wounds.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Wound Healing and Treatments · Antimicrobial Peptides and Activities
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, Hospital of Stomatology, Jilin University, Changchun 130021, Jilin, China
School of Stomatology, Jilin University, Jilin 130021, Changchun, China
Funding
National Natural Science Foundation of China
References (71)
Show source-provided references
1. 10.1016/S0140-6736(88)92730-410.1016/S0140-6736(88)92730-4 ↗
2. 10.1080/14787210.2019.155251810.1080/14787210.2019.1552518 ↗
3. 10.1007/s00134-016-4577-z10.1007/s00134-016-4577-z ↗
4. 10.1021/nn504262510.1021/nn5042625 ↗
5. 10.1126/sciadv.abn700610.1126/sciadv.abn7006 ↗
6. 10.1038/518810.1038/5188 ↗
7. 10.1039/D0MH01921F10.1039/D0MH01921F ↗
8. 10.1002/adhm.20220265210.1002/adhm.202202652 ↗
9. 10.1002/adma.20200604710.1002/adma.202006047 ↗
10. 10.1016/j.jconrel.2020.08.05510.1016/j.jconrel.2020.08.055 ↗
11. 10.1021/acsami.1c1826110.1021/acsami.1c18261 ↗
12. 10.1021/acsnano.9b0987110.1021/acsnano.9b09871 ↗
13. 10.1016/j.biotechadv.2018.11.00610.1016/j.biotechadv.2018.11.006 ↗
14. 10.1016/j.bioorg.2023.10655110.1016/j.bioorg.2023.106551 ↗
15. 10.1016/j.bioorg.2014.04.00510.1016/j.bioorg.2014.04.005 ↗
16. 10.1093/emboj/cdg36610.1093/emboj/cdg366 ↗
17. 10.1128/IAI.00046-1110.1128/IAI.00046-11 ↗
18. 10.1126/science.aam792810.1126/science.aam7928 ↗
19. 10.1111/wrr.1268310.1111/wrr.12683 ↗
20. 10.3390/pharmaceutics1302029110.3390/pharmaceutics13020291 ↗
21. 10.1039/D0MH01985B10.1039/D0MH01985B ↗
22. 10.3390/ijms2313727810.3390/ijms23137278 ↗
23. 10.1039/D0BM01213K10.1039/D0BM01213K ↗
24. 10.1021/la503911m10.1021/la503911m ↗
25. 10.1039/D0MH01317J10.1039/D0MH01317J ↗
26. 10.1016/j.lfs.2018.07.01710.1016/j.lfs.2018.07.017 ↗
27. 10.1111/jfbc.1422110.1111/jfbc.14221 ↗
28. 10.7150/ijms.4480410.7150/ijms.44804 ↗
29. 10.3389/fimmu.2022.93047610.3389/fimmu.2022.930476 ↗
30. 10.1111/exd.1296210.1111/exd.12962 ↗
31. 10.1111/jfbc.1342210.1111/jfbc.13422 ↗
32. 10.3748/wjg.v24.i16.167910.3748/wjg.v24.i16.1679 ↗
33. 10.1099/mic.0.049338-010.1099/mic.0.049338-0 ↗
34. 10.3389/fmolb.2020.0002510.3389/fmolb.2020.00025 ↗
35. 10.1016/j.biopha.2022.11291210.1016/j.biopha.2022.112912 ↗
36. 10.3389/fphar.2022.87218810.3389/fphar.2022.872188 ↗
37. 10.1021/acs.bioconjchem.8b0010310.1021/acs.bioconjchem.8b00103 ↗
38. 10.1073/pnas.171426711410.1073/pnas.1714267114 ↗
39. 10.1002/smll.20230966410.1002/smll.202309664 ↗
40. 10.1016/j.biomaterials.2023.12203610.1016/j.biomaterials.2023.122036 ↗
41. 10.7150/thno.4784110.7150/thno.47841 ↗
42. 10.1016/j.bioactmat.2023.12.02510.1016/j.bioactmat.2023.12.025 ↗
43. 10.1021/acs.nanolett.2c0256010.1021/acs.nanolett.2c02560 ↗
44. 10.1039/D2NR00487A10.1039/D2NR00487A ↗
45. 10.1021/acsami.4c0178310.1021/acsami.4c01783 ↗
46. 10.1002/adhm.20220165110.1002/adhm.202201651 ↗
47. 10.1016/j.ijpharm.2022.12250810.1016/j.ijpharm.2022.122508 ↗
48. 10.1002/smll.20220797310.1002/smll.202207973 ↗
49. 10.1038/nbt.333010.1038/nbt.3330 ↗
50. 10.1021/acs.accounts.9b0010310.1021/acs.accounts.9b00103 ↗
51. 10.1021/acsnano.9b0159110.1021/acsnano.9b01591 ↗
52. 10.1016/j.actbio.2023.02.02610.1016/j.actbio.2023.02.026 ↗
53. 10.1016/j.actbio.2023.12.04510.1016/j.actbio.2023.12.045 ↗
54. 10.1186/s12951-021-01128-410.1186/s12951-021-01128-4 ↗
55. 10.1016/j.biomaterials.2018.09.04510.1016/j.biomaterials.2018.09.045 ↗
56. 10.1021/acsmaterialslett.3c0092510.1021/acsmaterialslett.3c00925 ↗
57. 10.1016/j.biomaterials.2017.12.02710.1016/j.biomaterials.2017.12.027 ↗
58. 10.1016/j.actbio.2019.02.03210.1016/j.actbio.2019.02.032 ↗
59. 10.1021/acsami.9b2233910.1021/acsami.9b22339 ↗
60. 10.1016/j.jdent.2018.04.01310.1016/j.jdent.2018.04.013 ↗
61. 10.1021/acs.chemmater.1c0394410.1021/acs.chemmater.1c03944 ↗
62. 10.1021/acsami.2c0840610.1021/acsami.2c08406 ↗
63. 10.3390/foods1011261410.3390/foods10112614 ↗
64. 10.3390/ijms2313693910.3390/ijms23136939 ↗
65. 10.1016/j.molimm.2019.09.02010.1016/j.molimm.2019.09.020 ↗
66. 10.1002/JLB.3RU1018-378RR10.1002/JLB.3RU1018-378RR ↗
67. 10.1016/j.molimm.2012.07.00510.1016/j.molimm.2012.07.005 ↗
68. 10.7150/thno.8152010.7150/thno.81520 ↗
69. Wester J. · Lab Investigat. · 1979 · 41 · 182
70. 10.1021/acsami.3c0699610.1021/acsami.3c06996 ↗
71. 10.1021/acsami.1c1920910.1021/acsami.1c19209 ↗